Disclaimer: This summary is based solely on the provided text from the SEC filing and is for educational purposes only. It does not constitute financial advice.

📄 Proxy Statement 📜 What This Document Is

This is a definitive Proxy Statement (Form DEF 14A) filed by DaVita Inc. 🗓️. A Proxy Statement is a major document required annually that provides shareholders with all the information needed to vote at the upcoming annual meeting.

Unlike an earnings report, this document focuses on governance—the rules, people, and structures that guide the company. In essence, it tells shareholders how the company is run, who is on the board, and how decisions regarding pay and strategy are made.

👉 Key Takeaway: This filing is a governance blueprint, giving shareholders power by detailing their rights and the mechanics of board elections and oversight for the 2026 Annual Meeting.

🏢 Who Is DaVita Inc.? ⚕️ What The Company Does

DaVita Inc. is a large, specialized healthcare provider focused on kidney care and dialysis services. It provides critical, life-sustaining care to millions of people who require renal support.

👉 In simple terms, DaVita acts as a massive, national provider of care for patients with chronic kidney disease.

• The company emphasizes its "Trilogy of Care," which centers on its commitment to three pillars: caring for patients, caring for each other (teammates), and caring for the world (the community/planet).
• DaVita is structured to be an industry leader under the Centers for Medicare & Medicaid Services (CMS) Five-Star Rating System, which measures quality of care.

📣 CEO Highlights & 2025 Achievements 🚀 Key Milestones

The CEO, Javier J. Rodriguez, used the letter to reflect on 2025, highlighting the company’s resilience and growth during a dynamic healthcare environment. The message emphasizes operational strength and strategic focus.

👉 In 2025, DaVita focused on advanced clinical care and expanding its international presence while maintaining a high level of employee engagement, even after a major cybersecurity incident.

• Advanced Integrated Kidney Care (IKC): The company advanced this comprehensive value-based kidney care program, which led to differentiated clinical outcomes, including higher rates of permanent vascular access and greater adoption of home dialysis. This performance helped IKC reach profitability ahead of schedule.
• Scale of Care: DaVita empowered over 8,000 patients to receive a kidney transplant and continues its role in providing care globally.
• Global Expansion: DaVita expanded its international footprint by closing its acquisition in Brazil, bolstering its position as a major global provider of dialysis care.
• Cybersecurity Resilience: Despite a significant cybersecurity incident in April, the company managed the crisis by activating contingency plans and providing continuous care across more than 3,000 dialysis centers worldwide.

🌱 Corporate Social Responsibility (CSR) 🌍 Community Impact

DaVita makes a point of stressing that its mission is to be "a community first," detailing extensive efforts to give back and improve public health.

👉 The company reported impressive volunteerism and conservation metrics, demonstrating that its operational scale allows it to drive measurable positive social and environmental change.

• Health Education: Through a partnership with the American Diabetes Association (ADA), DaVita reached over 757,000 individuals with education on kidney disease prevention and management.
• Volunteerism: The company surpassed its five-year volunteerism goal early, reporting that teammates contributed more than 70,000 hours in 2025, reaching over 218,000 hours since 2021.
• Water & Environment: The company saved more than 90 million gallons of water through ongoing efficiency projects across its centers.
• Food Security: Through the DaVita Giving Foundation, the organization provided more than 23,000 medically tailored meals to people facing food insecurity.
• Future Commitment: DaVita plans to unveil new CSR 2030 goals, which will be available on their Community Care website.

🧑‍⚖️ Governance & Board Oversight 🏛️ How the Company is Run

Corporate governance concerns the rules and processes by which the company is controlled. This section details the board's commitment to strong oversight and stability.

👉 The Board operates through multiple specialized committees that ensure professional checks and balances—from auditing the books to guiding executive compensation.

• Governance Program: The Board maintains a comprehensive program that includes:
  • The annual election of all directors.
  • Stockholder right to call special meetings if they hold 10% or more of the stock.
  • No "poison pill" anti-takeover measures (meaning shareholders can directly influence the company).
• Leadership Structure: Pamela M. Arway has served as the independent Board Chair since June 2020. The Board structure is seen as beneficial because it supports independent oversight of management and increases accountability.
• Board Refreshment: The Board commits to evaluating its own composition and succession planning to maintain a blend of diverse skills, experience, and tenure.

🗳️ Director Nominations & Qualifications 🧑‍💼 Board Members

This section introduces the current board members and the nominees for re-election, providing context on their expertise and independent status.

👉 The board is highly experienced, bringing together expertise from diverse fields like global finance, healthcare technology, and financial services.

• Nominees: The Board has nominated nine individuals for re-election, including Pamela M. Arway, Barbara J. Desoer, Jason M. Hollar, Gregory J. Moore, M.D., Ph.D., Dennis W. Pullin, Javier J. Rodriguez, Adam H. Schechter, Wendy L. Schoppert, and Phyllis R. Yale.
• Independence: The Board determined that all director nominees, except the CEO, Javier J. Rodriguez, are independent under the New York Stock Exchange (NYSE) Standards.
• Skill Matrix: The Board believes its current directors provide a broad set of valuable skills, including:
  • Technology and AI Transformation
  • Cybersecurity
  • Global Regulatory and Public Policy knowledge
  • Expertise across Provider and Payor Healthcare systems
  • Human Capital Management (managing people)

💼 The Board Committees 📋 How Oversight is Structured

To manage its complex operations, the Board has established specialized committees. Each committee has specific, critical roles to protect shareholder interests and ensure regulatory compliance.

👉 Instead of one board, there are four specialized oversight groups, ensuring that complex areas like money, rules, and technology are managed by focused experts.

• Audit Committee: This committee monitors the quality and integrity of financial statements. It also oversees the independent accounting firm and assesses enterprise risk management (ERM), which includes cybersecurity risks.
• Compensation Committee: This committee designs and approves the company's executive pay philosophy. It reviews the CEO's total compensation package, ensuring it aligns with the company’s long-term goals and is approved by the Board.
• Nominating and Governance Committee: This committee handles board membership and rules. It oversees the evaluation of directors, determines the proper blend of skills and tenure on the board, and reviews corporate governance principles.
• Compliance and Quality Committee: This committee has the primary responsibility for overseeing healthcare regulatory compliance. It monitors patient safety, clinical quality metrics, and adherence to all federal healthcare laws and anti-corruption rules.

⚠️ Risk & Privacy Oversight 🔒 Protecting the Company

The Board has established a formal Enterprise Risk Management (ERM) process to proactively identify and manage potential threats to the company.

👉 Recognizing the critical nature of medical and financial data, the company uses a hybrid approach for cybersecurity that aligns with the National Institute of Standards and Technology (NIST) Cybersecurity Framework.

• Risk Assessment: The ERM team leads the process of assessing potential risks, using a "probability-magnitude lens" to determine which threats require the most immediate attention.
• Oversight Groups: Both the Audit Committee and the Compliance and Quality Committee receive regular updates and reports on these enterprise risks, ensuring the board level knows about potential issues from legal, security, and compliance perspectives.
• Data Focus: The risk process specifically includes monitoring risks related to data security and AI, reflecting the increasing reliance on technology in healthcare.

📢 Stakeholder Engagement & Communication 🗣️ Keeping Shareholders Informed

DaVita emphasizes that keeping lines of communication open with its shareholders is a core part of its business model and governance.

👉 The company employs a "year-round" engagement program, meaning they don't wait for the annual meeting to talk to shareholders.

• Outreach Commitment: Since the 2025 annual meeting, the company engaged with stockholders representing 59% of DaVita’s outstanding shares.
• Key Dialogue Topics: Discussions with stockholders focus on critical areas, including:
  • Corporate governance practices.
  • Executive pay and performance.
  • The impact of AI and cybersecurity on the business.
  • Sustainability and corporate responsibility.

📅 2026 Annual Meeting Details 🗓️ Next Steps for Shareholders

This section provides all the logistical information necessary for shareholders to participate in the annual meeting and vote on matters.

👉 The upcoming meeting is scheduled for Thursday, June 4, 2026. Shareholder action is required to vote on director elections and governance proposals.

• Date and Time: The 2026 Annual Meeting of Stockholders is scheduled for Thursday, June 4, 2026, at 10:00 AM Mountain Time.
• Materials: All necessary documents (Notice of Annual Meeting, Proxy Statement, and Annual Report) are available for viewing at www.proxyvote.com.
• Contact Information: For voting and details, stockholders can contact Investor Relations at 1-888-484-7505. For general board communication, writing to the Corporate Secretary at 2000 16th Street, Denver, Colorado 80202, is recommended.

🧠 The Analogy

Think of the Board of Directors and these various committees (Audit, Compensation, Compliance, etc.) like the governing body of a major university. They don't all do the same job. The President (CEO) runs the day-to-day operations. But the Board has specialized departments: the Finance Committee checks the budget and records (Audit); the Student Welfare Committee makes sure faculty and students are treated fairly and follow rules (Compliance); the Curriculum Committee decides how faculty are paid (Compensation); and the Admissions Committee selects the best candidates for faculty roles (Nominating and Governance). If any one of these areas failed, the whole university's reputation and function would suffer.

🧩 Final Takeaway

DaVita is using this Proxy Statement to signal deep organizational stability and mature governance, demonstrating that its commitment to oversight—from cybersecurity to ethical labor practices—is as robust as its commitment to delivering patient care.